APO RESEARCH · REPORT
0.9% Sodium Chloride Injection
0.9% Sodium Chloride Injection is a packaged sodium chloride solution for an identified medical-use specification.

Product & engineering
Understand the product.
Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which preparation and packaging specification is being purchased?
Solution composition, container volume, closure, sterility assurance and labelled route of use define the supplied preparation. Container appearance does not establish clinical suitability or administration instructions.
Selected research
Industry Growth & Trends
Global 0.9% Sodium Chloride Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global 0.9% Sodium Chloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 0.9% Sodium Chloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 0.9% Sodium Chloride Injection include Southwest Pharmaceutical Co., Ltd., Tonghua Golden-horse Pharmaceutical Industry Co.,ltd., Jiangsu Suzhong PHARMA Group Co., Ltd., Sichuan Kelun Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., SSY Group Limited, Shandong Weigao Pharmaceutical Co., Ltd., Novartis and Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global 0.9% Sodium Chloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The 0.9% Sodium Chloride Injection market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 0.9% Sodium Chloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 0.9% Sodium Chloride Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global 0.9% Sodium Chloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
0.9% Sodium Chloride Injection Market by Company
Southwest Pharmaceutical Co., Ltd.
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
SSY Group Limited
Shandong Weigao Pharmaceutical Co., Ltd.
Novartis
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Jiangsu Sihuan Bioengineering Co.,Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Pfizer
China Resources Double-crane Pharmaceutical Co.,Ltd.
Huaren Pharmaceutical Co.,Ltd.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Fresenius Kabi
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Cisen Pharmaceutical
PKU HealthCare Corp.,Ltd.
Baxter
Anhui Changjiang Pharmaceutical Co., Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Otsuka Pharmaceutical
BBraun
AstraZeneca plc.
Amphastar
0.9% Sodium Chloride Injection Segment by Type
100ml
250ml
500ml
Other
0.9% Sodium Chloride Injection Segment by Application
Hospitals
Clinics
Others
0.9% Sodium Chloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 0.9% Sodium Chloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 0.9% Sodium Chloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 0.9% Sodium Chloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 0.9% Sodium Chloride Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of 0.9% Sodium Chloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100ml
- 250ml
- 500ml
- Other
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Southwest Pharmaceutical Co., Ltd.
- Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
- Jiangsu Suzhong PHARMA Group Co., Ltd.
- Sichuan Kelun Pharmaceutical Co.,Ltd.
- Sichuan Biokin Pharmaceutical Co.,Ltd.
- SSY Group Limited
- Shandong Weigao Pharmaceutical Co., Ltd.
- Novartis
- Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
- Jiangsu Sihuan Bioengineering Co.,Ltd.
- Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- Jilin Province Dubang Pharmaceuticals Co., Ltd.
- Pfizer
- China Resources Double-crane Pharmaceutical Co.,Ltd.
- Huaren Pharmaceutical Co.,Ltd.
- Hebei TIANCHENG Pharmaceutical Co., Ltd.
- Hangzhou Minsheng Pharmaceutical Co., Ltd.
- Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- Fresenius Kabi
- CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
- Cisen Pharmaceutical
- PKU HealthCare Corp.,Ltd.
- Baxter
- Anhui Changjiang Pharmaceutical Co., Ltd.
- Anhui Fengyuan Pharmaceutical Co.,Ltd.
- Otsuka Pharmaceutical
- BBraun
- AstraZeneca plc.
- Amphastar
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 0.9% Sodium Chloride Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global 0.9% Sodium Chloride Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 0.9% Sodium Chloride Injection Market by Type
- 1.3.1 100ml
- 1.3.2 250ml
- 1.3.3 500ml
- 1.3.4 Other
- 1.4 Global 0.9% Sodium Chloride Injection Market Size by Type
- 1.4.1 Global 0.9% Sodium Chloride Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global 0.9% Sodium Chloride Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global 0.9% Sodium Chloride Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America 0.9% Sodium Chloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe 0.9% Sodium Chloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific 0.9% Sodium Chloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America 0.9% Sodium Chloride Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa 0.9% Sodium Chloride Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 0.9% Sodium Chloride Injection Industry Trends
- 2.2 0.9% Sodium Chloride Injection Industry Drivers
- 2.3 0.9% Sodium Chloride Injection Industry Opportunities and Challenges
- 2.4 0.9% Sodium Chloride Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by 0.9% Sodium Chloride Injection Revenue (2021-2026)
- 3.2 Global Top Players by 0.9% Sodium Chloride Injection Sales (2021-2026)
- 3.3 Global Top Players by 0.9% Sodium Chloride Injection Price (2021-2026)
- 3.4 Global 0.9% Sodium Chloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 0.9% Sodium Chloride Injection Major Company Production Sites & Headquarters
- 3.6 Global 0.9% Sodium Chloride Injection Company, Product Type & Application
- 3.7 Global 0.9% Sodium Chloride Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 0.9% Sodium Chloride Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 0.9% Sodium Chloride Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 0.9% Sodium Chloride Injection Tier 1, Tier 2, and Tier 3
4 0.9% Sodium Chloride Injection Regional Status and Outlook
- 4.1 Global 0.9% Sodium Chloride Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global 0.9% Sodium Chloride Injection Historic Market Size by Region
- 4.2.1 Global 0.9% Sodium Chloride Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global 0.9% Sodium Chloride Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global 0.9% Sodium Chloride Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global 0.9% Sodium Chloride Injection Forecasted Market Size by Region
- 4.3.1 Global 0.9% Sodium Chloride Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global 0.9% Sodium Chloride Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global 0.9% Sodium Chloride Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 0.9% Sodium Chloride Injection by Application
- 5.1 0.9% Sodium Chloride Injection Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global 0.9% Sodium Chloride Injection Market Size by Application
- 5.2.1 Global 0.9% Sodium Chloride Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global 0.9% Sodium Chloride Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global 0.9% Sodium Chloride Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America 0.9% Sodium Chloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe 0.9% Sodium Chloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific 0.9% Sodium Chloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America 0.9% Sodium Chloride Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa 0.9% Sodium Chloride Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Southwest Pharmaceutical Co., Ltd.
- 6.1.1 Southwest Pharmaceutical Co., Ltd. Company Information
- 6.1.2 Southwest Pharmaceutical Co., Ltd. Business Overview
- 6.1.3 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Southwest Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.1.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
- 6.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
- 6.2.1 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Company Information
- 6.2.2 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Business Overview
- 6.2.3 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.2.5 Tonghua Golden-horse Pharmaceutical Industry Co.,ltd. Recent Developments
- 6.3 Jiangsu Suzhong PHARMA Group Co., Ltd.
- 6.3.1 Jiangsu Suzhong PHARMA Group Co., Ltd. Company Information
- 6.3.2 Jiangsu Suzhong PHARMA Group Co., Ltd. Business Overview
- 6.3.3 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jiangsu Suzhong PHARMA Group Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.3.5 Jiangsu Suzhong PHARMA Group Co., Ltd. Recent Developments
- 6.4 Sichuan Kelun Pharmaceutical Co.,Ltd.
- 6.4.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
- 6.4.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Business Overview
- 6.4.3 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sichuan Kelun Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.4.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments
- 6.5 Sichuan Biokin Pharmaceutical Co.,Ltd.
- 6.5.1 Sichuan Biokin Pharmaceutical Co.,Ltd. Company Information
- 6.5.2 Sichuan Biokin Pharmaceutical Co.,Ltd. Business Overview
- 6.5.3 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sichuan Biokin Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.5.5 Sichuan Biokin Pharmaceutical Co.,Ltd. Recent Developments
- 6.6 SSY Group Limited
- 6.6.1 SSY Group Limited Company Information
- 6.6.2 SSY Group Limited Business Overview
- 6.6.3 SSY Group Limited 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 SSY Group Limited 0.9% Sodium Chloride Injection Product Portfolio
- 6.6.5 SSY Group Limited Recent Developments
- 6.7 Shandong Weigao Pharmaceutical Co., Ltd.
- 6.7.1 Shandong Weigao Pharmaceutical Co., Ltd. Company Information
- 6.7.2 Shandong Weigao Pharmaceutical Co., Ltd. Business Overview
- 6.7.3 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Shandong Weigao Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.7.5 Shandong Weigao Pharmaceutical Co., Ltd. Recent Developments
- 6.8 Novartis
- 6.8.1 Novartis Company Information
- 6.8.2 Novartis Business Overview
- 6.8.3 Novartis 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Novartis 0.9% Sodium Chloride Injection Product Portfolio
- 6.8.5 Novartis Recent Developments
- 6.9 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
- 6.9.1 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Company Information
- 6.9.2 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Business Overview
- 6.9.3 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.9.5 Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. Recent Developments
- 6.10 Jiangsu Sihuan Bioengineering Co.,Ltd.
- 6.10.1 Jiangsu Sihuan Bioengineering Co.,Ltd. Company Information
- 6.10.2 Jiangsu Sihuan Bioengineering Co.,Ltd. Business Overview
- 6.10.3 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Jiangsu Sihuan Bioengineering Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.10.5 Jiangsu Sihuan Bioengineering Co.,Ltd. Recent Developments
- 6.11 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- 6.11.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
- 6.11.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Business Overview
- 6.11.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.11.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
- 6.12 Jilin Province Dubang Pharmaceuticals Co., Ltd.
- 6.12.1 Jilin Province Dubang Pharmaceuticals Co., Ltd. Company Information
- 6.12.2 Jilin Province Dubang Pharmaceuticals Co., Ltd. Business Overview
- 6.12.3 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Jilin Province Dubang Pharmaceuticals Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.12.5 Jilin Province Dubang Pharmaceuticals Co., Ltd. Recent Developments
- 6.13 Pfizer
- 6.13.1 Pfizer Company Information
- 6.13.2 Pfizer Business Overview
- 6.13.3 Pfizer 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Pfizer 0.9% Sodium Chloride Injection Product Portfolio
- 6.13.5 Pfizer Recent Developments
- 6.14 China Resources Double-crane Pharmaceutical Co.,Ltd.
- 6.14.1 China Resources Double-crane Pharmaceutical Co.,Ltd. Company Information
- 6.14.2 China Resources Double-crane Pharmaceutical Co.,Ltd. Business Overview
- 6.14.3 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 China Resources Double-crane Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.14.5 China Resources Double-crane Pharmaceutical Co.,Ltd. Recent Developments
- 6.15 Huaren Pharmaceutical Co.,Ltd.
- 6.15.1 Huaren Pharmaceutical Co.,Ltd. Company Information
- 6.15.2 Huaren Pharmaceutical Co.,Ltd. Business Overview
- 6.15.3 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Huaren Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.15.5 Huaren Pharmaceutical Co.,Ltd. Recent Developments
- 6.16 Hebei TIANCHENG Pharmaceutical Co., Ltd.
- 6.16.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Company Information
- 6.16.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. Business Overview
- 6.16.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.16.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments
- 6.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
- 6.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
- 6.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
- 6.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
- 6.18 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- 6.18.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information
- 6.18.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Business Overview
- 6.18.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.18.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments
- 6.19 Fresenius Kabi
- 6.19.1 Fresenius Kabi Company Information
- 6.19.2 Fresenius Kabi Business Overview
- 6.19.3 Fresenius Kabi 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Fresenius Kabi 0.9% Sodium Chloride Injection Product Portfolio
- 6.19.5 Fresenius Kabi Recent Developments
- 6.20 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
- 6.20.1 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Company Information
- 6.20.2 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Business Overview
- 6.20.3 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. 0.9% Sodium Chloride Injection Product Portfolio
- 6.20.5 CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. Recent Developments
- 6.21 Cisen Pharmaceutical
- 6.21.1 Cisen Pharmaceutical Company Information
- 6.21.2 Cisen Pharmaceutical Business Overview
- 6.21.3 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Cisen Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
- 6.21.5 Cisen Pharmaceutical Recent Developments
- 6.22 PKU HealthCare Corp.,Ltd.
- 6.22.1 PKU HealthCare Corp.,Ltd. Company Information
- 6.22.2 PKU HealthCare Corp.,Ltd. Business Overview
- 6.22.3 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.22.4 PKU HealthCare Corp.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.22.5 PKU HealthCare Corp.,Ltd. Recent Developments
- 6.23 Baxter
- 6.23.1 Baxter Company Information
- 6.23.2 Baxter Business Overview
- 6.23.3 Baxter 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.23.4 Baxter 0.9% Sodium Chloride Injection Product Portfolio
- 6.23.5 Baxter Recent Developments
- 6.24 Anhui Changjiang Pharmaceutical Co., Ltd.
- 6.24.1 Anhui Changjiang Pharmaceutical Co., Ltd. Company Information
- 6.24.2 Anhui Changjiang Pharmaceutical Co., Ltd. Business Overview
- 6.24.3 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.24.4 Anhui Changjiang Pharmaceutical Co., Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.24.5 Anhui Changjiang Pharmaceutical Co., Ltd. Recent Developments
- 6.25 Anhui Fengyuan Pharmaceutical Co.,Ltd.
- 6.25.1 Anhui Fengyuan Pharmaceutical Co.,Ltd. Company Information
- 6.25.2 Anhui Fengyuan Pharmaceutical Co.,Ltd. Business Overview
- 6.25.3 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.25.4 Anhui Fengyuan Pharmaceutical Co.,Ltd. 0.9% Sodium Chloride Injection Product Portfolio
- 6.25.5 Anhui Fengyuan Pharmaceutical Co.,Ltd. Recent Developments
- 6.26 Otsuka Pharmaceutical
- 6.26.1 Otsuka Pharmaceutical Company Information
- 6.26.2 Otsuka Pharmaceutical Business Overview
- 6.26.3 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.26.4 Otsuka Pharmaceutical 0.9% Sodium Chloride Injection Product Portfolio
- 6.26.5 Otsuka Pharmaceutical Recent Developments
- 6.27 BBraun
- 6.27.1 BBraun Company Information
- 6.27.2 BBraun Business Overview
- 6.27.3 BBraun 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.27.4 BBraun 0.9% Sodium Chloride Injection Product Portfolio
- 6.27.5 BBraun Recent Developments
- 6.28 AstraZeneca plc.
- 6.28.1 AstraZeneca plc. Company Information
- 6.28.2 AstraZeneca plc. Business Overview
- 6.28.3 AstraZeneca plc. 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.28.4 AstraZeneca plc. 0.9% Sodium Chloride Injection Product Portfolio
- 6.28.5 AstraZeneca plc. Recent Developments
- 6.29 Amphastar
- 6.29.1 Amphastar Company Information
- 6.29.2 Amphastar Business Overview
- 6.29.3 Amphastar 0.9% Sodium Chloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.29.4 Amphastar 0.9% Sodium Chloride Injection Product Portfolio
- 6.29.5 Amphastar Recent Developments
7 North America by Country
- 7.1 North America 0.9% Sodium Chloride Injection Sales by Country
- 7.1.1 North America 0.9% Sodium Chloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America 0.9% Sodium Chloride Injection Sales by Country (2021-2026)
- 7.1.3 North America 0.9% Sodium Chloride Injection Sales Forecast by Country (2027-2032)
- 7.2 North America 0.9% Sodium Chloride Injection Market Size by Country
- 7.2.1 North America 0.9% Sodium Chloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America 0.9% Sodium Chloride Injection Market Size by Country (2021-2026)
- 7.2.3 North America 0.9% Sodium Chloride Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe 0.9% Sodium Chloride Injection Sales by Country
- 8.1.1 Europe 0.9% Sodium Chloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe 0.9% Sodium Chloride Injection Sales by Country (2021-2026)
- 8.1.3 Europe 0.9% Sodium Chloride Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe 0.9% Sodium Chloride Injection Market Size by Country
- 8.2.1 Europe 0.9% Sodium Chloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe 0.9% Sodium Chloride Injection Market Size by Country (2021-2026)
- 8.2.3 Europe 0.9% Sodium Chloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific 0.9% Sodium Chloride Injection Sales by Country
- 9.1.1 Asia-Pacific 0.9% Sodium Chloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific 0.9% Sodium Chloride Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific 0.9% Sodium Chloride Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific 0.9% Sodium Chloride Injection Market Size by Country
- 9.2.1 Asia-Pacific 0.9% Sodium Chloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific 0.9% Sodium Chloride Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific 0.9% Sodium Chloride Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America 0.9% Sodium Chloride Injection Sales by Country
- 10.1.1 South America 0.9% Sodium Chloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America 0.9% Sodium Chloride Injection Sales by Country (2021-2026)
- 10.1.3 South America 0.9% Sodium Chloride Injection Sales Forecast by Country (2027-2032)
- 10.2 South America 0.9% Sodium Chloride Injection Market Size by Country
- 10.2.1 South America 0.9% Sodium Chloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America 0.9% Sodium Chloride Injection Market Size by Country (2021-2026)
- 10.2.3 South America 0.9% Sodium Chloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country
- 11.1.1 Middle East and Africa 0.9% Sodium Chloride Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa 0.9% Sodium Chloride Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa 0.9% Sodium Chloride Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa 0.9% Sodium Chloride Injection Market Size by Country
- 11.2.1 Middle East and Africa 0.9% Sodium Chloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa 0.9% Sodium Chloride Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa 0.9% Sodium Chloride Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 0.9% Sodium Chloride Injection Value Chain Analysis
- 12.1.1 0.9% Sodium Chloride Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 0.9% Sodium Chloride Injection Production Mode & Process
- 12.2 0.9% Sodium Chloride Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 0.9% Sodium Chloride Injection Distributors
- 12.2.3 0.9% Sodium Chloride Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst